Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1151397 | 1.00 | GLP1R (1.00) | GLP1RAMY1A | |
| SCHEMBL3293485 | 1.00 | GLP1R (1.00) | GLP1RAMY1A | |
| SCHEMBL1151245 | 1.00 | GLP1R (1.00) | GLP1RAMY1A | |
| SCHEMBL1151471 | 1.00 | GLP1R (1.00) | GLP1RAMY1A | |
| SCHEMBL1151988 | 1.00 | GLP1R (1.00) | GLP1RAMY1A | |
| SCHEMBL12798935 | 1.00 | GLP1R (1.00) | GLP1RAMY1A | |
| SCHEMBL1151240 | 1.00 | GLP1R (1.00) | GLP1RAMY1A | |
| SCHEMBL1151242 | 1.00 | GLP1R (1.00) | GLP1RAMY1A | |
| SCHEMBL1151480 | 1.00 | GLP1R (1.00) | GLP1RAMY1A | |
| SCHEMBL13590579 | 1.00 | GLP1R (1.00) | GLP1RAMY1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3790549-A1 | THERAPEUTIC USES OF GLP1R AGONISTS | vTv Therapeutics LLC (US) | 2021-03-17 | — | — | EP | claimed |
| WO-2019217165-A1 | THERAPEUTIC USES OF GLP1R AGONISTS | VTV THERAPEUTICS LLC (US) | 2019-11-14 | — | — | WO | claimed |
| EP-3790549-A1 | THERAPEUTIC USES OF GLP1R AGONISTS | vTv Therapeutics LLC (US) | 2021-03-17 | — | — | EP | disclosed |
| WO-2019217165-A1 | THERAPEUTIC USES OF GLP1R AGONISTS | VTV THERAPEUTICS LLC (US) | 2019-11-14 | — | — | WO | disclosed |
| EP-2945618-B1 | COMBINATIONS OF A GLP1R AGONIST AND METFORMIN AND USE THEREOF FOR THE TREATMENT OF TYPE 2 DIABETES AND OTHER DISORDERS | VTV THERAPEUTICS LLC (US) | 2018-06-13 | — | — | EP | disclosed |